Marty Makary plans to resign as commissioner of the Food and Drug Administration on Tuesday, The Washington Times has confirmed.
Kyle Diamantas, the FDA’s deputy commissioner for food, will lead the agency in an acting capacity, the Times has also confirmed.
The resignation ends a contentious tenure at the FDA, which is responsible for overseeing the safety of food, drugs and veterinary products. Under Dr. Makary’s leadership, the agency drew criticism from Republicans for not reversing a Biden-era rule that let abortion drugs be mailed and dispensed via telehealth. He was also blasted by healthcare advocates after the FDA announced last week that it authorized fruit-flavored vapes for adults.
Neither the White House nor the FDA immediately responded to a request for comment. Politico first reported on Tuesday that Dr. Makary will resign.
Dr. Makary’s departure marks the fourth high-profile shake-up by President Trump in recent weeks. Since March, Mr. Trump has fired Homeland Security Secretary Kristi Noem and Attorney General Pam Bondi, with Labor Secretary Lori Chavez DeRemer resigning amid a misconduct probe.
